These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1461 related articles for article (PubMed ID: 26325307)

  • 1. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.
    Kim D; Lee ES; Park K; Kwon IC; Bae YH
    Pharm Res; 2008 Sep; 25(9):2074-82. PubMed ID: 18449626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs.
    Butt AM; Mohd Amin MC; Katas H
    Int J Nanomedicine; 2015; 10():1321-34. PubMed ID: 25709451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
    Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
    Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-triggered intracellular release from actively targeting polymer micelles.
    Guo X; Shi C; Wang J; Di S; Zhou S
    Biomaterials; 2013 Jun; 34(18):4544-54. PubMed ID: 23510854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
    Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
    Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
    Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
    Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers.
    Hong W; Chen D; Zhang X; Zeng J; Hu H; Zhao X; Qiao M
    Biomaterials; 2013 Dec; 34(37):9602-14. PubMed ID: 24021757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
    Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitization of doxorubicin in multidrug-resistant cells by unimolecular micelles via increased cellular accumulation and apoptosis.
    Wang M; Han M; Li Y; Jin Y; Gao JQ
    J Pharm Pharmacol; 2016 Mar; 68(3):333-41. PubMed ID: 26893058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
    Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
    Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
    Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y
    Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
    Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.
    Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z
    Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.